MESOBLAST LTD
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Large accelerated filer
State of Incorporation
Australia
Business Address
LEVEL 38, MELBOURNE, VICTORIA, C3, 3000
Mailing Address
LEVEL 38, MELBOURNE, VICTORIA, C3, 3000
Phone
613 9639 6036
Fiscal Year End
0630
EIN
000000000
Financial Overview
FY2022
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 10, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 3 Initial insider ownership report | April 1, 2026 | View on SEC |
| 3 Initial insider ownership report | April 1, 2026 | View on SEC |
| 3 Initial insider ownership report | April 1, 2026 | View on SEC |
| 3 Initial insider ownership report | March 23, 2026 | View on SEC |
| 6-K Foreign company current report | March 23, 2026 | View on SEC |
Insider Trading
STRONG BUY
1 insiders
15 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Scilex Holding Co
SCLX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Hemab Therapeutics Holdings, Inc.
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.